Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 31  |  Issue : 3  |  Page : 1073-1080

Impact of human cytomegalovirus on the response of chronic hepatitis C virus-infected patients to pegylated interferone and ribavirin combination therapy


1 Tropical Medicine Department, Faculty of Medicine, Menoufiya University, Shibin Al Kawm, Egypt
2 Department of Microbiology and Immunology, Faculty of Medicine, Menoufiya University, Shibin Al Kawm, Egypt
3 Department of Microbiology and Immunology, Shebin Elkowm Fever Hospital, Shibin Al Kawm, Egypt

Correspondence Address:
Sammar A Hassan El-Said
Shebin Elkowm Fever Hospital, Shibin Al Kawm
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.248746

Rights and Permissions

Objective The aim of this study was to study the impact of human cytomegalovirus infection in response rates of patients with chronic hepatitis C virus infection to pegylated interferon and ribavirin combination therapy. Background Cytomegalovirus affects the liver and overall immunological status of the host body. In chronic hepatitis C virus patients, co-infection with Cytomegalovirus could be an additional threat to the host and may contribute to the complexity of disease outcome. Patients and Methods This study was conducted on 40 patients with chronic hepatitis C virus infection candidates for pegylated interferon and ribavirin combination therapy. They were classified into two groups according to response to therapy. Group I (non-responders): included 20 chronic hepatitis C virus patients with any form of non response to therapy. They were 12 males (60%) and 8 females (40%). Group II (responders): included 20 patients with adequate response to therapy at the end of treatment (48 weeks). They were 9 males (45 %) and 11 females (55 %). Results There were significant increases in the number of patients with positive polymerase chain reaction for Human cytomegalovirus DNA in non-responders when compared with responders (14 out of 20 patients versus 5 out of 20 patients respectively). Conclusion Human cytomegalovirus is one of the independent factors that may significantly affect response of chronic hepatitis C virus patients to pegylated interferon and ribavirin combination therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed45    
    Printed0    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal